Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-21

Clinical Trial Update: AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing AVANDAMET to metformin in adults with type 2 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avandamet (rosiglitazone/metformin)
  • metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED